| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Chairman | 46 | 01/01/2020 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| +7.13% | +9.97% | +55.80% | +163.38% | 1,077B | |
| +3.99% | +11.50% | +67.09% | +56.27% | 613B | |
| +4.20% | +17.03% | +38.97% | +91.19% | 448B | |
| +0.36% | +4.85% | +28.17% | +22.04% | 332B | |
| -0.21% | +7.52% | +41.21% | +27.18% | 293B | |
| -0.59% | +4.29% | +30.44% | +40.74% | 286B | |
| -1.64% | +4.43% | -28.74% | -41.27% | 215B | |
| +1.56% | +6.14% | +29.30% | +61.91% | 193B | |
| +3.26% | +3.33% | +15.55% | +67.87% | 159B | |
| Average | +1.80% | +8.48% | +30.86% | +54.37% | 401.79B | |
| Weighted average by Cap. | +3.41% | +9.65% | +41.70% | +80.79% |
Employees
4
Sector
Pharmaceuticals
